The majority of patients with type 2 diabetes (T2D) have less than ideal metabolic control despite our greater understanding of the underlying pathophysiologic mechanisms of hyperglycemia and the ...

Researchers from several partner institutions of the German Center for Diabetes Research (DZD) have collaborated with ...

The approval of medicines called “glucagon-like peptide (GLP-1) agonists” has led to major changes in how type 2 diabetes is managed. These medicines work in a different way than other medicines used ...

People diagnosed with type 2 diabetes before age 40 face a higher lifetime risk of heart and kidney problems, so may benefit from adding another type of medicine called a GLP-1 receptor agonist (such ...

One of the most confusing aspects for patients with type 2 diabetes mellitus is that they have high fasting glucose levels. This is because in these insulin-resistant patients, glucose production by ...

Lifestyle changes such as eating a diabetes-friendly diet, exercising more, and maintaining a healthy body weight combined with existing treatment options are the best way to prevent or manage type 2 ...

Nutritional interventions, particularly supplements, are associated with significant improvements in anxiety among patients with T2D.

Type 2 diabetes is the most common form of diabetes. It can be diagnosed at any age and increases your risk of several other health problems. Farxiga (far-see-guh) is just one of the many prescription ...

An international clinical trial has found that an oral form of semaglutide, a widely used diabetes drug, reduced the risk of serious heart failure events in people with type 2 diabetes who already had ...

Biomea Fusion presented positive data on icovamenib for type 2 diabetes, showing improved glycemic control and weight loss in clinical trials. Biomea Fusion announced promising new data for icovamenib ...